WebDiabetes mellitus type 1 or 2, and age 40–75 years, with LDL-C 70–189 mg/dL. 10-year ASCVD risk ≥ 7.5%and age 40–75years (see Table 2 for calculation information). ... In selected individuals who are not in the four main statin benefit groups (see Table 5), and for whom a decision to initiate statin ... WebAug 1, 2013 · In BriefDiabetes is considered a risk equivalent for stroke heart disease (CHD). The use of statins for primary both secondary prevention in patients with diab
Who to Treat with Statins National Institutes of Health (NIH)
WebApr 1, 2024 · Adults with diabetes mellitus Moderate-intensity statin therapy is indicated in adults with diabetes, regardless of their 10-year risk. … WebJan 15, 2024 · If 40 to 75 years of age with diabetes and LDL-C of 70 to 189 mg per dL (1.81 to 4.90 mmol per L), use a moderate-intensity statin (unless 10-year ASCVD risk ≥ 7.5%, in which case use a high ... cnn.gr news
Effects of Race on Statin Prescribing for Primary Prevention With …
WebOct 5, 2024 · Statin users had a 37% higher rate of progression of diabetes than their matched cohort. Progression as measured by Increasing prescription of glucose-lowering medications Initiation of insulin Presence of persistently elevated blood sugars New onset of poorly or uncontrolled diabetes WebStatins, also known as HMG-CoA reductase inhibitors, are a class of lipid-lowering medications that reduce illness and mortality in those who are at high risk of cardiovascular disease.They are the most common cholesterol-lowering drugs. Low-density lipoprotein (LDL) carriers of cholesterol play a key role in the development of atherosclerosis and … WebAug 23, 2024 · The likelihood of benefit is smaller in this group than in persons with a 10-year risk of 10% or greater. C: ... MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380(9841):565-571. 22. Panozzo CA, Curtis LH, Marshall J, et al ... cnn griffith